In a new study, Dana-Farber Cancer Institute scientists disprove a
century-old theory about why cancer cells often have too many or too few
chromosomes, and show that the actual reason may hold the key to a
novel approach to cancer therapy.
Since the late 19th century, scientists have attributed the surplus
or shortage of intact chromosomes in cancer cells to a kind of
fragmentation in cell division: Instead of dividing neatly into two
identical daughter cells, as normal cells do, cancer cells were thought
to frequently split into three or four cells, each with a motley
assortment of chromosomes. This explosive division was thought to occur
because many cancer cells have extra centrosomes, tiny circular
structures that help pairs of chromosomes line up in preparation for
cell division.
When study lead author Neil Ganem, PhD, of Dana-Farber used newly
developed microscope equipment to watch living cancer cells for a week
or more, he found that not only were such abnormal divisions quite rare,
but the resulting daughter cells were so discombobulated by their
chromosomal quirks, they generally survived for only a few days — far
too briefly to deliver abnormal chromosome content to a tumor.

Neil Ganem, PhD, left, lead author of the study, talks with lab colleagues.
The way that extra centrosomes do cause chromosome instability, Ganem
and his colleagues have discovered, is by setting up a tug-of-war for
chromosomes that are eventually caught between newly forming daughter
cells of a dividing cancer cell. In normal cells, which have two
centrosomes, division occurs as the pairs of chromosomes split neatly
apart, like halves of a zipper, each set moving into one of the daughter
cells. The extra centrosomes in cancer cells exert an unequal pull on
some chromosomes, causing the daughter cells to inherit an irregular
number of them — explaining, in part, why tumors are often filled with
cells of varying quantities of chromosomes.
Their findings are reported in the journal Nature as an advanced online publication.
"Chromosome instability is a hallmark of most cancer cells, arising
when chromosomes are mis-segregated into daughter cells during
division," said Ganem, who led the study with senior author David
Pellman, MD, and co-author Susana Godinho, PhD, of Dana-Farber. "Such
instability may be a double-edged sword. It may confer a survival
benefit on cancer cells by enabling them to adapt to a stressful
environment in the body or by helping them become resistant to
chemotherapy drugs. But it may also have deleterious effects that could
make tumor cells susceptible to therapeutic attack."
"Although centrosome defects have been recognized in tumors for a
long time," Pellman said, "it has been a tough problem to rigorously
study. Neil and Susana have made a significant advance by developing
useful methods to create comparable cells that carry or don't carry
extra centrosomes."
In the early stages of division, cells make duplicate copies of their
chromosomes, enabling their daughter cells to each receive an identical
set. The centrosomes' role is to construct the mitotic spindle, the
axis along which the chromosome pairs position themselves as division
proceeds.
In normal cells, the two centrosomes serve as the polar ends of the
spindle, the chromosomes arrayed between them like ranks of twin
soldiers. Cells with more than two centrosomes enter a "multipolar"
phase with several axes along which division may take place. Under a
microscope, such cells look briefly like a sliced pizza ready to be
pulled into three or four pieces.
But cancer cells usually avoid this fate by clustering extra
centrosomes in a rough line, allowing a single spindle to form and
division to proceed somewhat normally. In a study last year,
researchers from Pellman's lab used genome-wide approaches to discover
how this clustering occurs. In the current study, the investigators
found that when cancer cells with extra centrosomes enter "anaphase" —
the stage of cell division when chromosomes move toward the poles of the
spindle before being drawn into the new daughter cells — a few
chromosomes lagged behind the others. As a result, some of those
chromosomes became homeless — left out of the daughter cell they were
destined for, and marooned in the other daughter cell, where they
inhabit a kind of island outside the nucleus where the other chromosomes
congregate.
"We showed that even though most cancer cells with extra centrosomes
form a single mitotic spindle, they pass through a brief 'multipolar
spindle' stage," Ganem said. "The presence of this unique spindle
configuration causes a few chromosomes to attach improperly to the
eventual two-ended spindle. That, in turn, disrupts the normally orderly
process by which chromosomes are pulled into the daughter cells."
According to Pellman, chromosomal instability, it turns out, "is
actually a side-effect of the cells' ability to cluster their excess
centrosomes. From the standpoint of the tumor cell, it is a trade-off:
the cell survives because it can correct for the surplus centrosomes,
but the correction process creates other problems that result in
chromosomal instability."
While the new study demonstrates that extra centrosomes are major
actors — but likely not the only ones — in chromosome instability, it is
an open question as to what causes some cells to have those extra
centrosomes. That will be a future area of research for the Dana-Farber
team.
The study was funded in part by a National Institutes of Health grant.